01 1Viatris
01 1CANAGLIFLOZIN
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-01-12
Pay. Date : 2016-08-19
DMF Number : 30771
Submission : 2016-08-30
Status : Active
Type : II
20
Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CANAGLIFLOZIN, with a corresponding US DMF Number 30771.
Remarkably, this DMF maintains an Active status since its submission on August 30, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 12, 2017, and payment made on August 19, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II
